Treatments on the Horizon: Breast Cancer Patients with Central Nervous System Metastases

被引:0
|
作者
Aaron Kaplan
Min Jun Li
Rachna Malani
机构
[1] Weill Cornell Medicine,Department of Neurology
[2] Memorial Sloan Kettering Cancer Center,Department of Neurology
[3] MSKCC Human Oncology and Pathogenesis Program,undefined
[4] Memorial Sloan Kettering Cancer Center,undefined
来源
Current Oncology Reports | 2022年 / 24卷
关键词
Breast Cancer; Brain metastases; Leptomeningeal metastases; Radiation therapy; Intrathecal treatment; Systemic treatment; Immunotherapy; CAR-T; Blood–brain-barrier;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:343 / 350
页数:7
相关论文
共 50 条
  • [31] Diagnosis and management of central nervous system metastases from breast cancer
    Chang, EL
    Lo, S
    ONCOLOGIST, 2003, 8 (05): : 398 - 410
  • [32] Capecitabine therapy of central nervous system metastases from breast cancer
    Ekenel, Meltem
    Hormigo, Adilia M.
    Peak, Scott
    DeAngelis, Lisa M.
    Abrey, Lauren E.
    JOURNAL OF NEURO-ONCOLOGY, 2007, 85 (02) : 223 - 227
  • [33] Correction to: Systemic Therapy of Central Nervous System Metastases of Breast Cancer
    José Pablo Leone
    Nancy U. Lin
    Current Oncology Reports, 2019, 21
  • [34] Current Therapeutic Options for Breast Cancer Central Nervous System Metastases
    Hemphill, M. Brian
    Lawrence, Julia A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2008, 9 (01) : 41 - 50
  • [35] Current Therapeutic Options for Breast Cancer Central Nervous System Metastases
    M. Brian Hemphill
    Julia A. Lawrence
    Current Treatment Options in Oncology, 2008, 9 : 41 - 50
  • [36] Evaluating Cancer Drugs in Patients With Central Nervous System Metastases
    Marur, Shanthi
    Beaver, Julia A.
    Pazdur, Richard
    JAMA ONCOLOGY, 2021, 7 (08) : 1111 - 1112
  • [37] Characteristics of breast cancer patients with central nervous system metastases: A single-center experience
    Harputluoglu, Hakan
    Dizdar, Omer
    Aksoy, Sercan
    Kilickap, Saadettin
    Dede, Didem S.
    Ozisik, Yavuz
    Guler, Nilufer
    Barista, Ibrahim
    Gullu, Ibrahim
    Hayran, Mutlu
    Selek, Ugur
    Cengiz, Mustafa
    Zorlu, Faruk
    Tekuzman, Gulten
    Altundag, Kadri
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2008, 100 (05) : 521 - 526
  • [38] PHARMACOECONOMIC ANALISYS OF TRASTUZUMAB EMTANZINE IN PATIENTS WITH METASTATIC BREAST CANCER AND CENTRAL NERVOUS SYSTEM METASTASES
    Kolbin, A.
    Kurylev, A.
    Balykina, Y.
    Proskurin, M.
    VALUE IN HEALTH, 2017, 20 (09) : A438 - A438
  • [39] Cerebrospinal fluid cytokeratins for diagnosis of patients with central nervous system metastases from breast cancer
    Sölétormos, G
    Bach, F
    CLINICAL CHEMISTRY, 2001, 47 (05) : 948 - 950
  • [40] Does trastuzumab increase the risk of isolated central nervous system metastases in patients with breast cancer?
    Weill, RJ
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (05): : 236 - 237